DPLPharmaceuticals
Dipna Pharmachem Ltd — PE Ratio & Valuation Analysis
₹8.02
-2.59%
Current P/E19.71xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E16.0x23.2% above avg
✅
38.0% Discount to Industry
DPL P/E 19.71x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹0.90 | ₹14 | 16x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Dipna Pharmachem Ltd Valuation
Dipna Pharmachem Ltd (DPL) currently trades at 19.71x earnings. The Pharmaceuticals sector average PE is 31.77x. DPL is trading at a discount to peers — may indicate relative value. Historically, DPL has traded at an average PE of 16.0x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
2.55%
Dividend Yield
0.00%
More on Dipna Pharmachem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.